AnaptysBio Inc buy Guggenheim
Start price
05.11.25
/
50%
€31.20
Target price
05.11.26
€87.01
Performance (%)
26.92%
Price
27.01.26
€41.00
Summary
This prediction is currently active. The BUY prediction by Guggenheim currently has a performance of 26.92%. This prediction currently runs until 05.11.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 1.026% | 1.026% |
| iShares Core DAX® | 1.130% | 2.184% |
| iShares Nasdaq 100 | 1.128% | -0.611% |
| iShares Nikkei 225® | 2.610% | 4.958% |
| iShares S&P 500 | -0.006% | -0.952% |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio (NASDAQ:ANAB) had its price target raised by analysts at Guggenheim from $90.00 to $100.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat

